SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer (NSCLC). A UK Randomized Phase III Trial

被引：0
|
作者：
Ngai, Yenting [1 ]
Hanna, Gerard [2 ]
Conibear, John [3 ]
Counsell, Nicholas [1 ]
Hughes, Laura [1 ]
Farrelly, Laura [1 ]
Landau, David [4 ]
机构：
[1] Cr Uk & UCL Canc Trials Ctr, London, England
[2] Belfast City Hosp, Belfast, Antrim, North Ireland
[3] St Bartholomews Hosp, London, England
[4] Guys & St Thomas NHS Fdn Trust, Oncol, London, England
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
Stereotactic ablative radiotherapy (SABR); Stereotactic radiosurgery (SRS); Oligometastatic; non-small cell lung cancer (NSCLC);
D O I：
10.1016/j.jtho.2016.11.2185
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.06-003
引用
收藏
页码：S1425 / S1426
页数：2
相关论文
共 50 条
  • [31] The Role of Stereotactic Ablative Radiotherapy for Early-Stage and Oligometastatic Non-small Cell Lung Cancer: Evidence for Changing Paradigms
    Dahele, Max
    Senan, Suresh
    CANCER RESEARCH AND TREATMENT, 2011, 43 (02): : 75 - 82
  • [32] Lobectomy versus stereotactic ablative radiotherapy for medically operable patients with stage IA non-small cell lung cancer: A virtual randomized phase III trial stratified by age
    Seo, Young-Seok
    Kim, Hak Jae
    Wu, Hong Gyun
    Choi, Sun Mi
    Park, Samina
    THORACIC CANCER, 2019, 10 (06) : 1489 - 1499
  • [33] Non-small Cell Lung Cancer Stereotactic ablative Radiotherapy vs. Lobectomy
    Lorenz, Judith
    ZENTRALBLATT FUR CHIRURGIE, 2016, 141 (03): : 237 - 237
  • [34] Stereotactic radiotherapy (SRT) in combination with aumolertinib to treat intracranial oligometastatic non-small cell lung cancer (NSCLC): A phase II, prospective study
    Chen, J. Y.
    Zhang, H.
    Wang, B. Y.
    Wen, J. M.
    Xu, X. Y.
    Li, H. T.
    Fan, M.
    ANNALS OF ONCOLOGY, 2022, 33 : S1588 - S1588
  • [35] Stereotactic ablative radiotherapy (SABR) in medically inoperable early stage non-small cell lung cancer (NSCLC): A single tertiary UK centre experience
    Yip, C.
    Landau, D. B.
    Thomas, C.
    Ahmad, S.
    LUNG CANCER, 2013, 79 : S58 - S58
  • [36] A Randomized, Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High-Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC)
    Martha E. Teke
    Amber Leila Sarvestani
    Jonathan M. Hernandez
    Hiran C. Fernando
    Robert D. Timmerman
    Annals of Surgical Oncology, 2022, 29 : 4686 - 4687
  • [37] A Randomized, Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High-Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC)
    Teke, Martha E.
    Sarvestani, Amber Leila
    Hernandez, Jonathan M.
    Fernando, Hiran C.
    Timmerman, Robert D.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (08) : 4686 - 4687
  • [38] Stereotactic body radiotherapy improves the survival of patients with oligometastatic non-small cell lung cancer
    Ouyang, Wen
    Yu, Jing
    Nuerjiang, Shuake
    Li, Zhijun
    Wang, Dajiang
    Wang, Xiaoyong
    Zhang, Junhong
    Xie, Conghua
    CANCER MEDICINE, 2019, 8 (10): : 4605 - 4614
  • [39] Stereotactic Ablative Fractionated Radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the Lung: A Randomized Phase II Trial
    Siva, S.
    Bressel, M.
    Kron, T.
    Mai, T.
    Le, H. V.
    Montgomery, R.
    Hardcastle, N.
    Rezo, A.
    Gill, S.
    Higgs, B. G.
    Pryor, D. I.
    Lourenco, R. De Abreu
    Awad, R.
    Chesson, B.
    Eade, T. N.
    Skala, M.
    Sasso, G.
    Wong, W.
    Vinod, S.
    Ball, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S3 - S4
  • [40] Radiotherapy for oligometastatic tumor improved the prognosis of patients with non-small cell lung cancer (NSCLC)
    Gong, Hong-yun
    Wang, Yi
    Han, Guang
    Song, Qi-bin
    THORACIC CANCER, 2019, 10 (05) : 1136 - 1140
12345